STK16
MOLECULAR TARGETserine/threonine kinase 16
STK16 (serine/threonine kinase 16) is targeted by 10 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting STK16
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Quercetin | 1.10 | 2 |
| 2 | sp600125 | 1.10 | 2 |
| 3 | Apigenin 5,7,4'-trihydroxy-flavone, | 0.69 | 1 |
| 4 | chrysin | 0.69 | 1 |
| 5 | fisetin | 0.69 | 1 |
| 6 | Kaempferols | 0.69 | 1 |
| 7 | Luteolin 5,7,3',4'-tetrahydroxy-flavone, | 0.69 | 1 |
| 8 | Axitinib | 0.69 | 1 |
| 9 | pictilisib | 0.69 | 1 |
| 10 | Sorafenib | 0.69 | 1 |
About STK16 as a Drug Target
STK16 (serine/threonine kinase 16) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 10 compounds with documented STK16 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
STK16 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.